Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sartorius Stedim Biotech
  6. News
  7. Summary
    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sartorius Stedim Biotech SA : DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL

01/04/2021 | 05:15am EDT
 
 Sartorius Stedim Biotech SA 
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES 
AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL 
 
04-Jan-2021 / 11:13 CET/CEST 
Dissemination of a French Regulatory News, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
 
Sartorius Stedim Biotech S.A. - 13781 Aubagne Cedex, France 
 
      DECLARATION RELATIVE TO 
 
      THE NUMBER OF SHARES AND VOTING RIGHTS 
 
      MAKING UP THE ISSUED CAPITAL 
 
      Article L 233-8-II of the Code of commerce 
 
      and article 223-6 of the general regulations of the AMF 
 
      Designation of issuer 
 
      SARTORIUS STEDIM BIOTECH SA 
 
      CS 91051 
 
      Z. I. Les Paluds 
 
      Avenue de Jouques 
 
      13781 Aubagne Cedex 
 
     Date of        Total number   Total number  Total number of 
   information       of shares    of theoretical   net voting 
                   making up the  voting rights      rights 
                   issued capital   including 
                                     treasury 
                                      shares 
December 31, 2020    92,180,190    160,531,960     160,530,867 
 
Regulatory filing PDF file 
 
File: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING 
UP THE ISSUED CAPITAL [1] 
 
Language:        English 
Company:         Sartorius Stedim Biotech SA 
                 Avenue de Jouques 
                 13781 Aubagne 
                 France 
Phone:           +33 44 284 5600 
E-mail:          info@sartorius-stedim.com 
Internet:        www.sartorius-stedim.com 
ISIN:            FR0013154002 
Euronext Ticker: DIM 
AMF Category:    Total number of voting rights and share capital / 
                 Information on the total number of voting rights and the 
                 number of shares making up the share capital 
EQS News ID:     1158208 
 
End of Announcement EQS News Service 
 
1158208 04-Jan-2021 CET/CEST 
 
 
1: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=ee9fb9b4660918581bb87441fa2fa43e&application_id=1158208&site_id=vwd&application_name=news 
 

(END) Dow Jones Newswires

January 04, 2021 05:13 ET (10:13 GMT)

Stocks mentioned in the article
ChangeLast1st jan.
SARTORIUS AG 1.57% 583 Delayed Quote.66.38%
SARTORIUS STEDIM BIOTECH 2.56% 480.6 Real-time Quote.61.16%
All news about SARTORIUS STEDIM BIOTECH
10/20GLOBAL MARKETS LIVE : Kering, Netflix, Roche, United Airlines, Xiaomi...
10/20PRESS RELEASE : Curexsys Appoints Christian Eckert as Chief Operating Officer
DJ
10/20SARTORIUS STEDIM BIOTECH : Q3 Profit Soars On Significant Demand Momentum
MT
10/20SARTORIUS' : Nine-Month Profit Soars Almost 93% On Strong Revenue Growth
MT
10/20SARTORIUS STEDIM BIOTECH : Earnings Release 9M|2021
PU
10/20SARTORIUS STEDIM BIOTECH : grows dynamically and profitably – Substantial...
PU
10/20SARTORIUS STEDIM BIOTECH : Nine-month results of Sartorius Stedim Biotech
PR
10/13SARTORIUS : Heir Agrees on Changes to Joint Heirship
MT
10/13SARTORIUS AG : Release according to Article 40, Section 1 of the WpHG [the German Securiti..
DJ
10/08VIDEO : This week's gainers and losers
More news
Analyst Recommendations on SARTORIUS STEDIM BIOTECH
More recommendations
Financials
Sales 2021 2 830 M 3 297 M 3 297 M
Net income 2021 613 M 714 M 714 M
Net Debt 2021 444 M 518 M 518 M
P/E ratio 2021 70,6x
Yield 2021 0,26%
Capitalization 43 260 M 50 373 M 50 405 M
EV / Sales 2021 15,4x
EV / Sales 2022 13,7x
Nbr of Employees 8 746
Free-Float 26,2%
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | DIM | FR0013154002 | MarketScreener
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 469,30 €
Average target price 444,33 €
Spread / Average Target -5,32%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chairman & Chief Executive Officer
Oscar-Werner Reif Executive VP-Research & Development
Volker Niebel Executive VP-Operations & Information Technology
Henri Riey Independent Non-Executive Director
Anne-Marie Graffin Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS STEDIM BIOTECH61.16%50 373
ABBOTT LABORATORIES12.62%218 606
MEDTRONIC PLC3.97%163 906
BECTON, DICKINSON AND COMPANY-1.33%70 907
HOYA CORPORATION22.25%56 339
DEXCOM, INC.50.53%53 845